Counterfeit of medicines causes 37,000 job losses in EU Pharma Industry

Counterfeit medicine is an increasing problem for public health and economy. This is no longer a problem of certain regions such as Asia and Africa. It has now also become an issue in the EU and US. The European Union Intellectual Property Office (EUIPO) published a press release on 29 September 2016 in which they state that fake medicines cost the EU pharmaceutical sector 10.2 billion Euro every year. Read more about the latest figures on counterfeit medicines

http://www.gmp-compliance.org/enews_05605_Counterfeit-of-medicines-causes-37-000-job-losses-in-EU-Pharma-Industry_15356,S-QSB_n.html

Counterfeit medicine is an increasing problem for public health and economy. This is no longer a problem of certain regions such as Asia and Africa. It has now also become an issue in the EU and the US. In the past, counterfeit medicines could not enter the legal supply chain in the EU and US. But the problem has now also been arising in western countries. A number ofcases of counterfeit medicines were…